RE:re stock price crashI agree. There are two things here: the technicals of the trial, and the business aspect. I understand people want to know what the results and %'s mean and to be more clear on the PR. But from a business and investor stand point, we need to understand the "what now?" or "what's next?" Need to know timelines and what the future state will be. Management, for the interest of the company and shareholders should have evaluated options and next steps if the results were positive or negative, and provide direction in either case. Hopefully it comes out soon, but I want to know what they will file with the FDA for approval, under what basis, and what timeline we can expect.